See more : PreVu, Inc. (PRVU) Income Statement Analysis – Financial Results
Complete financial analysis of DNAPrint Genomics, Inc. (DNAG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DNAPrint Genomics, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Cathedra Bitcoin Inc. (CBTTF) Income Statement Analysis – Financial Results
- SNC Former Public Company Limited (SNC.BK) Income Statement Analysis – Financial Results
- Codexis, Inc. (CDXS) Income Statement Analysis – Financial Results
- PT Garuda Maintenance Facility Aero Asia Tbk (GMFI.JK) Income Statement Analysis – Financial Results
- Slam Corp. (SLAM) Income Statement Analysis – Financial Results
DNAPrint Genomics, Inc. (DNAG)
Industry: Biotechnology
Sector: Healthcare
About DNAPrint Genomics, Inc.
DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.
Source: https://incomestatements.info
Category: Stock Reports